Micreos develops the world's first targeted antibacterial products, set to replace antibiotics. With Micreos' endolysin technology, for the first time it is possible to kill only the unwanted bacteria - including antibiotic resistant strains such as MRSA - while leaving our microbiome - comprising billions of beneficial bacteria on our skin and in our gut - intact. In addition, research shows that the use of endolysins does not induce resistance. This unlocks a completely new approach in dealing with the bacteria around us: killing the bad bacteria and preserving the microbiome.
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the Up!Rotterdam network.
Something looks off?
Open jobs at Micreos
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.